Breast Cancer News
In this section, access cutting-edge breast cancer news on treatment updates, emerging therapies, study results and other medical and quality-of-life issues important to you.
NEW YORK (Reuters Health) - Older women who are diagnosed with early-stage breast cancer can expect to live just as long as peers without breast cancer, according to a new study.
Sentinel lymph node dissection was as effective as axillary lymph node surgery at lengthening lives but caused fewer painful side effects in this landmark study of women with invasive, early-stage breast cancer.
Early results from the Neo-ALTTO show that two medicines used together before surgery substantially increased response rates in HER2 positive early-stage breast cancer.
CHICAGO (Reuters) - Scientists know that being overweight increases the risk of breast cancers fed by estrogen, but being too fat may also increase the risk of triple-negative breast cancers, a less common and far more deadly type, U.S. researchers said on Tuesday.
CHICAGO (Reuters) - Breast cancer rates among U.S. white women have stopped falling, U.S. researchers said on Monday, suggesting that the fallout from a 2002 study linking hormone replacement therapy to breast cancer was short lived.
NEW YORK (Reuters Health) - Screening mammography is less accurate at spotting breast cancer if a woman has had the disease before, according to a new government-funded study.
WASHINGTON (Reuters) - Women who start hormone replacement therapy (HRT) as they begin to go through menopause have a higher risk of breast cancer than women who start taking the drugs later, researchers reported on Friday.
Results from two studies presented at the San Antonio Breast Cancer Symposium (SABCS) show no association between CYP2D6 levels and tamoxifen effectiveness in postmenopausal women.
NEW YORK (Reuters Health) - Women treated for breast cancer with radiation therapy are more likely to die from heart disease 20 years or more down the line than women who don't get radiation, according to a new study.
Roche/Genentech, maker of Avastin (bevacizumab), has requested a hearing before the U.S. Food and Drug Administration to appeal the agency’s December 2010 decision to withdraw approval of bevacizumab as a treatment for metastatic breast cancer.